Core Insights - WELL Health Technologies Corp. provides a corporate update on its subsidiary WELLSTAR Technologies, highlighting significant organic and inorganic growth, including a $62 million Series B financing round and strategic acquisitions [2][3][12]. WELLSTAR's Growth and Strategy - WELLSTAR has established itself as Canada's leading digital health platform, driven by organic growth and a growing recurring revenue base [3]. - The company aims for a potential public listing in 2026 while focusing on empowering clinicians with advanced digital tools [3]. OceanMD eReferral Platform - OceanMD has secured a significant eReferral contract, increasing WELLSTAR's Annual Recurring Revenue (ARR) by 16% [4][5]. - The platform now facilitates over 1.7 million eReferrals annually, supported by more than 20,000 physicians and 3,800 clinics across Canada [5][6]. - OceanMD has demonstrated improvements in patient care, including a 12% reduction in unnecessary MRIs and a 20% reduction in surgical wait times [7]. Recent Acquisitions - WELLSTAR has signed agreements to acquire two billing assets expected to generate approximately $4 million in annualized revenue with margins exceeding 20% [9]. - The acquisition of Mutuo Health Solutions enhances WELLSTAR's AI capabilities and aligns its products with clinical workflows [10]. Financial Performance - WELLSTAR reported Q3 revenue of $18.3 million, a 67% increase year-over-year, with organic growth of 26% [11]. - The company's ARR grew 63% year-over-year, indicating a scalable and durable business model [11]. Future Growth Plans - Following the $62 million financing, WELLSTAR is pursuing strategic acquisitions to expand its technology suite and aims for a $100 million annualized run rate [12]. - The company is actively advancing its M&A pipeline and has added a new member to its corporate development team [12].